Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Heart Failure
Heart Failure Monitoring Technology Doubles Sensitivity for Predicting Events While Minimizing False Alerts Versus Standard of Care
03/07/2024

Bodyport Inc. News

Bodyport Inc. News
Bodyport Inc. announced data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
Bodyport Inc. announced data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care.
Bodyport Inc. announced data...
03/07/2024
Cath Lab Digest
Heart Failure
Endotronix Presents Positive PROACTIVE-HF Clinical Trial Results for its Cordella Pulmonary Artery Sensor
03/07/2024

Endotronix News

Endotronix News
The trial met primary safety and efficacy endpoints and demonstrated a markedly low rate of HF hospitalizations in addition to showing a clinically significant improvement in patient quality of life, increased physical activity, and...
The trial met primary safety and efficacy endpoints and demonstrated a markedly low rate of HF hospitalizations in addition to showing a clinically significant improvement in patient quality of life, increased physical activity, and...
The trial met primary safety and...
03/07/2024
Cath Lab Digest

Advertisement

IVL
FastWave Earns Third Utility Patent for Next-Generation IVL Technology
03/06/2024

FastWave Medical News

FastWave Medical News
The patent supports the design of FastWave's next-generation intravascular lithotripsy (IVL) system, which aims to address challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The patent supports the design of FastWave's next-generation intravascular lithotripsy (IVL) system, which aims to address challenges associated with treating calcified arteries in patients with occlusive vascular disease.
The patent supports the design...
03/06/2024
Cath Lab Digest
Carotid Artery Revascularization
Silk Road Medical Expands TCAR Portfolio with Launch of Tapered ENROUTE Transcarotid Stent System
03/05/2024

Silk Road Medical News

Silk Road Medical News
This launch expands upon the company’s prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.
This launch expands upon the company’s prior ENROUTE Transcarotid Stent System, offering additional configurations to better tailor the Transcarotid Artery Revascularization (TCAR) procedure to patient anatomy.
This launch expands upon the...
03/05/2024
Cath Lab Digest
Self-expanding covered stent (BD)
IDE Study
BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease
03/05/2024

BD (Becton, Dickinson and Company) News

BD (Becton, Dickinson and Company) Ne...
The investigational device exemption (IDE) study "AGILITY" will assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Peripheral Arterial Disease (PAD). 
The investigational device exemption (IDE) study "AGILITY" will assess the safety and effectiveness of the BD Vascular Covered Stent for the treatment of Peripheral Arterial Disease (PAD). 
The investigational device...
03/05/2024
Cath Lab Digest

Advertisement

BioCardia CardiAMP
Heart Failure
BioCardia Reports Positive Interim Results From Phase III CardiAMP Cell Therapy Heart Failure Trial, With Compelling Data in Subgroup With Elevated NTproBNP Biomarker for Heart Failure
03/04/2024

BioCardia, Inc., News

BioCardia, Inc., News
In a subgroup analysis of patients with elevated NTproBNP at baseline – encompassing 59% of total enrolled randomized patients – patients treated with CardiAMP cell therapy experienced an 86.2% relative risk reduction in heart death...
In a subgroup analysis of patients with elevated NTproBNP at baseline – encompassing 59% of total enrolled randomized patients – patients treated with CardiAMP cell therapy experienced an 86.2% relative risk reduction in heart death...
In a subgroup analysis of...
03/04/2024
Cath Lab Digest
A volunteer wears the ECGI vest.
New Technology
Electrocardiographic Imaging (ECGI) Vest Can Detect Earlier Signs of Hypertrophic Cardiomyopathy
03/01/2024

University College London News

University College London News ...
The ECGI vest has 256 sensors rather than the 12 used in a standard electrocardiogram (ECG) and can provide detailed electrical mapping of the heart in just five minutes.
The ECGI vest has 256 sensors rather than the 12 used in a standard electrocardiogram (ECG) and can provide detailed electrical mapping of the heart in just five minutes.
The ECGI vest has 256 sensors...
03/01/2024
Cath Lab Digest
DCB
FDA Approves Boston Scientific's AGENT Drug-Coated Balloon (DCB) for Coronary In-Stent Restenosis
03/01/2024

Boston Scientific News

Boston Scientific News
The AGENT DCB is a paclitaxel-coated balloon catheter that transfers a therapeutic dose of drug to the vessel wall to help prevent in-stent restenosis occurrence.
The AGENT DCB is a paclitaxel-coated balloon catheter that transfers a therapeutic dose of drug to the vessel wall to help prevent in-stent restenosis occurrence.
The AGENT DCB is a...
03/01/2024
Cath Lab Digest

Advertisement

Dr. Eric A. Secemsky
Medical Advisory Boards
RAMPART IC Adds Dr. Eric Secemsky to Its Medical Advisory Board
02/29/2024
RAMPART IC is pleased to announce that renowned interventional cardiologist Eric A. Secemsky M.D. will join the company’s growing Medical Advisory Board to help guide Rampart’s mission to offer better radiation protection solutions for teams...
RAMPART IC is pleased to announce that renowned interventional cardiologist Eric A. Secemsky M.D. will join the company’s growing Medical Advisory Board to help guide Rampart’s mission to offer better radiation protection solutions for teams...
RAMPART IC is pleased to...
02/29/2024
Cath Lab Digest
Guidelines
Aorta Recognized as Independent Organ for First Time
02/28/2024

University of Freiburg News

University of Freiburg News
"The new guidelines clearly recommend bundling the treatment of the aorta in a separate specialty, naturally in close coordination with other specialties," says cardiovascular surgeon and Professor Martin Czerny.
"The new guidelines clearly recommend bundling the treatment of the aorta in a separate specialty, naturally in close coordination with other specialties," says cardiovascular surgeon and Professor Martin Czerny.
"The new guidelines clearly...
02/28/2024
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use